You just read:

New NIH funding for studies of suspicious microbes will accelerate solving Alzheimer's disease, says Dr. Leslie Norins, CEO of Alzheimer's Germ Quest, Inc.

News provided by

Alzheimer's Germ Quest, Inc.

Apr 09, 2019, 03:05 ET